Tavistock Life Sciences

Tavistock Life Sciences

Tavistock Life Sciences

Tavistock Group is an international private investment organization founded by Joe Lewis more than 40 years ago and built on a core philosophy: We strive for excellence in everything we do.
Follow us
MedCity News

FDA green-lights second RET inhibitor, this time from Blueprint Medicines


Lilly and Avidity Biosciences Sign Licensing and Research Collaboration Deal

Undisclosed funding

Avidity Biosciences Receives Equity Investment from CureDuchenne

Funding Health Science

Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street

Health Science
$10,000,000 Venture capital (Series B)
biospace , PE Hub , prnewswire

Avidity Biosciences Raises 16 Million In Series B Financing To Advance Antibody Sirna Conjugate Platform

$125,000,000 Post-IPO debt

Biotech Day on Twitter

$45,000,000 Venture capital

Ambrx Closes $45M Financing Round

Funding Health
Xconomy , FinSMEs

G1 Therapeutics Hauls in $47M for Lung, Breast Cancer Trials

Health Funding

Blueprint, Roche Ink Milestone Deal for Cancer Immunotherapy

Health Science
$6,000,000 Venture capital (Series B)
PE Hub

Avidity NanoMedicines racks up $6 mln